Pages that link to "Q34046668"
Jump to navigation
Jump to search
The following pages link to Therapeutic rationale for antithrombin III in sepsis (Q34046668):
Displaying 30 items.
- PAMPs and DAMPs as triggers for DIC (Q27013790) (← links)
- Heparin in interventional radiology: a therapy in evolution (Q33394179) (← links)
- A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis (Q33753012) (← links)
- Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. (Q33815424) (← links)
- Coagulation dysfunction in sepsis and multiple organ system failure (Q34212373) (← links)
- Recent developments in the management of haemophagocytic lymphohistiocytosis (Q34390355) (← links)
- Plasminogen activators in inflammation and sepsis (Q34777701) (← links)
- Emerging therapies in severe sepsis (Q34938586) (← links)
- Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (Q35017874) (← links)
- Such stuff as dreams are made on: mediator-directed therapy in sepsis (Q35128911) (← links)
- New approaches to the treatment of sepsis (Q35622651) (← links)
- Coagulation in sepsis (Q35775912) (← links)
- Interactions between coagulation and complement--their role in inflammation (Q36022738) (← links)
- The Interplay between Inflammation, Coagulation and Endothelial Injury in the Early Phase of Acute Pancreatitis: Clinical Implications. (Q37690857) (← links)
- Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan (Q38209738) (← links)
- Antithrombin-III attenuates hepatocyte apoptosis in bile duct ligated rat: a striking cellular change (Q38343752) (← links)
- Anticoagulant modulation of inflammation in severe sepsis (Q38457021) (← links)
- The role of heparin in sepsis: much more than just an anticoagulant. (Q38612382) (← links)
- Disseminated intravascular coagulation - new pathophysiological concepts and impact on management (Q38851774) (← links)
- Common variable immune deficiency associated Hodgkin's lymphoma complicated with EBV-linked hemophagocytic lymphohistiocytosis: a case report (Q40917510) (← links)
- Enoxaparin versus unfractioned heparin as anticoagulant for continuous venovenous hemodialysis: a randomized open-label trial (Q43108541) (← links)
- The effects of antithrombin-III on inducible nitric oxide synthesis in experimental obstructive jaundice. An immunohistochemical study (Q44166262) (← links)
- Prognostic value of plasma pro-adrenomedullin and antithrombin levels in neonatal sepsis (Q46513189) (← links)
- The role of protein C in sepsis (Q46953002) (← links)
- Expression and functional characterization of two natural heparin-binding site variants of antithrombin. (Q48159506) (← links)
- Antithrombin and near-fatal exertional heat stroke (Q51707755) (← links)
- Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies (Q57293851) (← links)
- Antithrombin: An anticoagulant, anti-inflammatory and antibacterial serpin (Q89950751) (← links)
- The effect of antithrombin added to recombinant human-soluble thrombomodulin for severe community-acquired pneumonia-associated disseminated intravascular coagulation: a retrospective cohort study using a nationwide inpatient database (Q92758350) (← links)
- The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review (Q99711257) (← links)